Warren Hirsch - 17 Mar 2024 Form 4 Insider Report for ProPhase Labs, Inc. (PRPH)

Reporting relationship: Director
Issuer ticker: PRPH
Reported as of: 17 Mar 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 19 Mar 2024, 21:50:15 UTC
Prior SEC filing: 21 Jun 2023
Next SEC filing: 18 Feb 2025
Source filing: View source filing
Reporting owner signature: /s/ Warren Hirsch

Key filing fact

Warren Hirsch filed Form 4 for ProPhase Labs, Inc. (PRPH) on 19 Mar 2024.

Key facts

This page summarizes Warren Hirsch's Form 4 filing for ProPhase Labs, Inc. (PRPH).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 19 Mar 2024, 21:50.

Change

Previous filing in this sequence was filed on 21 Jun 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PRPH transaction Derivative

Option (right to buy)

Award

Transaction value: $0
Shares: +70,000
Change %
Price: $0.000000
Shares after: 70,000
Date: 17 Mar 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 70,000
Exercise price: $6.00
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Options shall vest and become exercisable in four equal installments, with 25% of such award vesting and becoming exercisable on each of September 30, 2024, December 31, 2024, March 31, 2025 and June 30, 2025 provided the recipient continues to serve as a non-employee director of the Issuer on each such vesting date.